Table 3.
Opportunistic pathogens associated with secondary infections.
| Micro-Organisms | Total (n = 92) | Bloodstream Infection (n = 31) | VAP (n = 46) | cUTI (n = 15) |
|---|---|---|---|---|
| Gram-positive cocci | ||||
| Enterococcus faecalis | 8 (8.6%) | 3 (9.7%) | 5 (33%) | |
| Enterococcus faecium | 2 (2.1%) | 2 (6.4%) | ||
| MSSA | 8 (8.6%) | 8 (17.4%) | ||
| MRSA | 4 (3.2%) | 3 (9.7%) | 1 (2.2%) | |
| Streptococcus anginosus | 1 (1.1%) | 1 (3.2%) | ||
| Staphylococcus epidermidis | 2 (2.1%) | 2 (6%) | ||
| Gram-negative bacilli | ||||
| Enterobacterales | ||||
| Escherichia coli | 9 (9.7%) | 3 (5%) | 6 (40%) | |
| Klebsiella spp. | 10 (10.7%) | 4 (13%) | 6 (13%) | |
| Enterobacter, Morganella morganii, Citrobacter spp. | 12 (13%) | 2 (6.4%) | 8 (17.4%) | 2 (13.3%) |
| Proteus | 1 (1.1%) | 1 (6.6%) | ||
| Serratia | 5 (5.4%) | 3 (9.7%) | 2 (4.4%) | |
| Non-fermenting GNB | ||||
| Acinetobacter baumannii | 19 (20.4%) | 5 (16.1%) | 14 (25.5%) | |
| Pseudomonas spp. | 6 (6.4%) | 3 (9.7%) | 2 (4.4%) | 1 (6.6%) |
| Stenotrophomonas maltophilia | 2 (2.1%) | 2 (4.4%) | ||
| Fungi | ||||
| Candida spp. | 3 (3.2%) | 3 (9.7%) | ||
| Aspergillus spp. | 2 (2.1%) | 2 (4.4%) |
Table 3 MSSA: methicillin-susceptible Staphylococcus aureus; MRSA: methicillin-resistant Staphylococcus aureus; GNB: gram negative bacteria.